Potentially accelerates development, assessment, and review for approval by FDA Sepsis impacts about 1.7 million U.S. adults ...

Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical ...

The Company remains on track to complete 12-month visits by early Q2 2027. Envoy Medical has submitted two of the four ...

In September 2026, the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation approved ...

A second victim of the September 11 attacks has been identified with breakthrough genetic genealogy, which combines DNA ...

Texas hospital uses Skincubator technology to help parents hold premature babies safely. Learn more about this innovation.

Doctors are more likely to dismiss women’s symptoms as being “all in their head” than those of male patients, research ...

The rapid adoption of generative AI and the rise of 'AI agents' that autonomously perform tasks have brought about dramatic ...

The Kansas City Chiefs avoided a historic Super Bowl era stat on Sunday, snapping a three-game stretch without a sack during ...

Johnson & Johnson guides to 8.2% adjusted EPS growth at its 2026 midpoint, compared with approximately 7% implied by 2026 ...

Soon if you visit a medical specialist, you may notice a fact sheet plastered on the wall. It will encourage you to ask questions, and outline five simple things to consider when speaking to your ...

Remaining milestones: The company expects to submit two additional modules, including the final module containing clinical trial data, towards the end of the second quarter in 2027.